R1OP34

R$280.00

0.00%

wb_incandescent Backtest

Stock

Roper Technologies, Inc.

Official Company Name: Roper Technologies, Inc.

Stock Symbol: R1OP34

Stock Market: B3 - Bovespa

Currency: Brazilian real - BRL

business Roper Technologies, Inc. Company Profile

R1OP34 Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▲+26.91%

file_download

Daily closing prices, with moving averages and volumes - Brazilian real (BRL)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Roper Technologies, Inc. is a diversified industrial and technology company that provides engineered products and solutions for a variety of niche end markets. Through a number of subsidiary companies, Roper manufactures and markets computers, scientific and industrial imaging equipment and software, pumps and specialized machinery for heavy industries, together with a wide range of specialized machines, software, and technologies.

business Roper Technologies, Inc. Company Profile

R1OP34 Stock Data

Open R$280.00
High R$280.00
Low R$280.00
Close R$280.00
Volume 0
Previous Close R$280.00
1-Day Change 0.00
1-Year Change 59.37
Average Daily Volume 30
52-Week High R$280.00
52-Week Low R$220.63
warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.